Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition
Hyerim Jung, Yoonji Lee, DongHoon Yu…·Tae-Kyung Kim
This study shows that Q901, a CDK7 inhibitor, enhances cancer susceptibility to TOP1 inhibitors by stabilizing TOP1-DPCs and suppressing DNA repair pathways.